000			03133nam a22004695i 4500
001			978-3-642-02400-9
003			DE-He213
005			20140220083255.0
007			cr nn 008mamaa
008			130107s2012 gw | s |||| 0|eng d
020			_a9783642024009 _9978-3-642-02400-9
024	7		_a10.1007/978-3-642-02400-9 _2doi
050		4	_aR895-920
072		7	_aMMN _2bicssc
072		7	_aMED080000 _2bisacsh
082	0	4	_a616.07548 _223
100	1		_aFogelman, Ignac. _eeditor.
245	1	0	_aRadionuclide and Hybrid Bone Imaging _h[electronic resource] / _cedited by Ignac Fogelman, Gopinath Gnanasegaran, Hans Wall.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg : _bImprint: Springer, _c2012.
300			_aXIV, 1046 p. 641 illus., 294 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
520			_aThe accurate identification of pathology in the skeleton is an extremely important goal, and the great strength of the radionuclide bone scan is its ability to identify functional change before structural change occurs. Over the years, the indications for bone scan have evolved to include benign disorders as well as malignancies. Further striking developments include the emergence of PET and of new tracers that offer enhanced capabilities, such as 18F-fluoride. The most dramatic advance, however, has been the development of hybrid imaging systems that combine the strengths of different modalities. This book, written by authors with national and international reputations in the field, covers all aspects of radionuclide and hybrid bone imaging. Introductory sections present the basic science and consider the current status and limitations of conventional radiological techniques. The underlying principles of PET-CT and SPECT-CT are carefully explained, and the value of different PET and SPECT tracers, assessed. The role of single- and dual-modality approaches in the imaging of benign bone diseases and malignancies is then discussed in detail in a series of well-illustrated chapters. The pathologies addressed include metabolic bone disease, arthritis, bone and joint infections, primary bone and soft tissue tumors, and metastases from breast and prostate cancer. A further section considers the role of bone scintigraphy in the pediatric patient, and the closing chapters focus on miscellaneous subjects, including bone densitometry and radionuclide targeted therapy.
650		0	_aMedicine.
650		0	_aNuclear medicine.
650		0	_aOncology.
650		0	_aOrthopedics.
650	1	4	_aMedicine & Public Health.
650	2	4	_aNuclear Medicine.
650	2	4	_aOncology.
650	2	4	_aOrthopedics.
700	1		_aGnanasegaran, Gopinath. _eeditor.
700	1		_aWall, Hans. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783642023996
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-642-02400-9
912			_aZDB-2-SME
999			_c101810 _d101810